Interferon-Free Drug Combo MK-5172 and MK-8742 ± Ribavirin
Written by: Jonathan Simmons | Last reviewed: January 2019.
- Tai AW, Chung RT. Investigational therapies for hepatitis C virus infection. Uptodate. Di Bisceglie AM, Bloom A, eds. Accessed at: www.uptodate.com. 2014.
- Gentile I, Coppola N, Buonomo AR, Zappulo E, Borgia G. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opin Investig Drugs 2014;21:1-13.
- Gane EJ, Ben Ari Z, Mollison L, et al. Efficacy and safety of an interferon-free regimen of MK-5172 + ribavirin for 12 weeks or 24 weeks in treatment naive, non-cirrhotic subjects with HCV GT1 infection: the C-SPIRIT study. Hepatology 2013;58:748-9.